NICE’s processes of technology evaluation - presenting a case for change

4 Feb 2021 01:03 PM

NICE has today (4 February 2021) launched a public consultation on proposals for changes to the processes it uses to develop its guidance on medicines, medical devices, diagnostics and digital health technologies

This consultation is the third in a series of consultations on proposals for changes to the methods and processes NICE uses to produce its guidance on health technologies – part of the largest review ever undertaken by NICE.

The proposals are now subject to public consultation until Tuesday, 15 April. They explore opportunities for:

Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Assessment at NICE, said: “Ensuring rapid access to clinically and cost-effective health technologies is critically important to patients and their families, the NHS and the life sciences industry. To continue to support the needs and aspirations of all parts of the healthcare and life sciences ecosystem, NICE must ensure that its processes of health technology evaluation maintain and improve upon key objectives regarding quality, dependability, speed, flexibility and cost.

“These proposals present an important opportunity to achieve these objectives. By doing so, not only will NICE be better able to support patients and the NHS in accessing clinically and cost-effective health technologies, it will also ensure that we can play our part in ensuring the UK remains a first-launch country for important and promising new health technologies.”

“We’ve learnt a great deal over the past 21 years during which we have continued to evolve and adapt our processes and methods to meet the challenges of an ever-changing healthcare environment.  

“These proposals build on that experience. They outline how we aim to focus our health technology evaluations on not just final guidance as the main ‘output’, but on moving towards ‘health technology management’, where support for early development, early advice, adoption, real world performance and reassessment are targeted to ensuring that the needs of patients and the NHS are front and centre in our activities.”

Read the process consultation document here: